Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: Jim Roof who wrote (1209)	2/16/2000 4:21:00 PM
From: Rusti H	Respond to of 1972

As a holder of this stock on and off for years, my gut reaction is to pretend nothing is happening and hope I don't rock the boat. God knows, tech stocks blow up in our faces every day, but vicl has been such a steady little company I can only believe that something big is happening here and that people who know a lot more than I are stocking up. rusti

To: Jim Roof who wrote (1209)	2/16/2000 6:49:00 PM
From: William Strop	Respond to of 1972

Jim, That is an interesting question that is probably answered differently by each individual depending on their investment horizon, when they bought, why they bought, etc.... From a historical perspective on Vical, here is my opinion. On March 7, 1994 I first read about Vical in "Barron's" where M. Murphy was interviewed. He had a target of $100 for the end of 1996. Needless to say, 1994 was the start of the 5 year biotech bear market & $100 in 1996 was never realized. To give some perspective of where they were at that time, on 3/4/94 they announced clearance for the first Phase I/II for Allovectin-7; on 5/4/94 Merck licensed the use of naked dna for 2 more vaccines (bringing the total to 4); on 12/2/96 Vical received core naked dna technology patent; on 1/2/97 Vical received naked dna vaccine patent; and so on... From when I started to follow them, I have never seen them fail. No barn burners, but no failures. These little successes have added to their strength/position as a Company without being reflected in the market cap. We know how many trips between 12 - 16 were taken!!! So, finally IMO, the $100 target that was set FOR 1996 is no longer valid when one looks at where the Company was then & where it is now. Actually $100 in 1996 would have made Vical the stock a greater value than Vical the Company... In 2000, $100 makes Vical the stock a lower value that Vical the Company. So, I guess I continue to wait patiently for the market cap. to catch up to the Company. Bill ps. Sorry if I rambled, but I just tried to sum up six years of patience in a few paragraphs.

To: Jim Roof who wrote (1209)	2/18/2000 11:11:00 PM
From: Scott H. Davis	Read Replies (1) \| Respond to of 1972

Jim, I took about 40% off the table back at 28 1/2 approx, so my anxiaty is not too high. Stock is only moderatly ovebought on a daily chart basis, more so on a weekly. siliconinvestor.com Think a lot of mo-players & newbies just discovering this sector now have a material share of the shares, so profit taking and/or bailing on a retrace is becomming a material risk. Having held beiotech thru the bad, I may be somewhat handicapped now - so many of the biotechs I was following have soared well above historical valuations that I have not pulled the trigger recently. IMSCO Scott